Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

Experimental Hematology

Volumn 34, Issue 12, 2006, Pages 1616-

  Huston, Alissa ^a   Brown, Jason ^a   Roodman, G David ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; THALIDOMIDE;

ACUTE KIDNEY FAILURE; AGED; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG PULSE THERAPY; HEMODIALYSIS; HUMAN; LETTER; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN LAMBDA-CHAINS; KIDNEY FAILURE; MALE; MULTIPLE MYELOMA; THALIDOMIDE; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME;

EID: 33751551620     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.07.010     Document Type: Letter

References (5)

1. Cany L., Fitoussi O., Boiron J.M., and Marit G. Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma. J Clin Oncol 20 (2002) 2212
2. Fuente N., Mane J.M., Barcelo R., Munoz A., Perez-Hoyos T., and Lopez-Vivanco G. Tumor lysis syndrome in a multiple myeloma treated with thalidomide. Ann Oncol 15 (2004) 537
3. Terpos E., Politou M., and Rahemtulla A. Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration. J Cancer Res Clin Oncol 130 (2004) 623-625
4. van de Kerkhof J.J., Peters W.G., Visser J., and Creemers G.J. Acute tumor lysis syndrome in a patient with multiple myeloma treated with dexamethasone monotherapy. Neth J Med 59 (2001) 83-85
5. Fassas A.B., Desikan K.R., Siegel D., et al. Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma. Br J Haematol 105 (1999) 938-941